NCT06809049

Brief Summary

The goal of this interventional study is to demonstrate the feasibility and tolerability of music and movement intervention for children with congenital DM1, while providing indications of its effectiveness in improving brain and heart symptoms of DM1. Additionally, information from the collection of biological samples and wearable devices (accelerometer, EEG headband and ECG chest strap) will be used to identify brain-heart biomarkers and outcome measures for use in future research and trials. Researchers will compare the results of physical and cognitive assessments for each participant to assessments from baseline after 10 weeks of weekly music sessions. Qualitative measures (questionnaires and focus groups) will inform the feasibility of this intervention for this population. The main questions this study aims to answer are:

  • Are weekly music education sessions feasible for children with DM1?
  • Are weekly music education sessions tolerable for children with DM1? Participants will:
  • Attend 45-minute-long music sessions once weekly for 10 weeks.
  • Attend two clinic visits for cognitive and physical assessments.
  • Provide blood, saliva, stool and urine samples.
  • Use wearable devices both at-home and during music sessions.
  • Parents/caregivers of participants will complete questionnaires and participate in three focus groups. Progression from feasibility study to a full-scale clinical trial will be informed by four progression criteria:
  • The feasibility of attendance, as assessed by attendance rate to 10 music sessions (≥ 60%)
  • Feasibility of attendance, as rated by parents/caregivers of participants (≥60% rate "extremely" or "very" practical to attend)
  • Attrition rate of the study, as determined by percentage of participants who complete the study (≥ 60%)
  • Overall satisfaction, as rated by parents/caregivers of participants (≥60% rate "very satisfied" or "satisfied")

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
1mo left

Started Mar 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Mar 2025Jul 2026

First Submitted

Initial submission to the registry

January 27, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 5, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

March 25, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Last Updated

February 19, 2026

Status Verified

February 1, 2026

Enrollment Period

1.3 years

First QC Date

January 27, 2025

Last Update Submit

February 17, 2026

Conditions

Keywords

Music interventionMyotonic dystrophyDM1Rare disease

Outcome Measures

Primary Outcomes (3)

  • Attendance to Each Music Session

    Participant attendance rate to 10 music sessions.

    Over 10-week block of music sessions

  • Attendance to Block of Music Sessions

    The proportion of participants who attend all 10 music sessions.

    Over 10-week block of music sessions

  • Qualitative Feedback from Parents/Caregivers Following Each Music Session

    Parents/Caregivers will complete short questionnaires following each of the 10 music sessions. Questions will focus on recall of participant mood, tiredness and engagement in the 24 hours immediately following each music session.

    Following each music session through to the final music session.

Secondary Outcomes (22)

  • Change in Physical Performance Assessed by the 6-Minute Walk Test (6MWT)

    Baseline and 1 week following the final music session.

  • Change from Baseline in Clinical Phenotype Assessed by the Clinician-Completed Congenital DM1 Rating Scale (CDM1-RS)

    Baseline and 1 week following the final music session.

  • Change in Global IQ Assessed by Wechsler Abbreviated Scale of Intelligence Second Edition (WASI-II)

    Baseline and 1 week following the final music session.

  • Change in Attention Assessed by Bells Assessment

    Baseline and 1 week following the final music session.

  • Change in Working Memory Assessed by NIH List Sorting Working Memory Test

    Baseline and 1 week following the final music session.

  • +17 more secondary outcomes

Study Arms (1)

Music Intervention

EXPERIMENTAL

All participants will receive weekly music and movement education sessions.

Behavioral: Music and movement education

Interventions

The music and movement intervention is partially inspired by an adaptive music-education method called Dalcroze eurhythmics. It focuses on free and improvised movement, as well as structure and choreographed sequences. It has been successfully applied to similar populations as an effective, accessible, and sustainable intervention. We hope to use this music and movement education to employ a holistic approach to improve the brain-heart symptoms of children with congenital DM1.

Music Intervention

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Participants between the ages of 6 to 18 with genetically confirmed congenital or infantile-onset myotonic dystrophy type 1 (DM1).
  • Participants willing to stay on stable medication from the day of screening to end of study.

You may not qualify if:

  • Insufficient English language skills to complete required assessments and questionnaires.
  • Participant is non-verbal.
  • Failure to provide signed informed consent by participant or designated decision maker (i.e. parent, legal guardian or power of attorney).
  • Failure to provide signed informed consent by parents/caregivers for dyad participation.
  • Participant is not a resident of Canada, due to risk of attrition.
  • Patients for whom - in the opinion of the investigator - it would not be safe to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital of Eastern Ontario

Ottawa, Ontario, K1H 8L1, Canada

RECRUITING

MeSH Terms

Conditions

Myotonic DystrophyRare Diseases

Condition Hierarchy (Ancestors)

Muscular DystrophiesMuscular Disorders, AtrophicMuscular DiseasesMusculoskeletal DiseasesMyotonic DisordersHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesNervous System DiseasesNeuromuscular DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Participants will be grouped with 3-7 other participants of similar age and ability for the music education sessions. All participants will receive the music intervention.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Senior Scientist

Study Record Dates

First Submitted

January 27, 2025

First Posted

February 5, 2025

Study Start

March 25, 2025

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

February 19, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

De-identified quantitative data including, results of cognitive and physical assessments and wearable device measurements.

Shared Documents
STUDY PROTOCOL, ICF
Access Criteria
IPD will be stored within the ARCHIMEDES health data portal and accessible to qualified researchers with a research plan approved by a data access committee. Supporting information (protocol and informed consent forms) will be available as a publication.

Locations